Results 211 to 220 of about 57,775 (326)

Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome. [PDF]

Lupus
Morán Álvarez P, Bracaglia C, Nicolai R, Giovannelli L, Caiello I, Boni A, Matteo V, Moneta GM, Messia V, De Benedetti F, Marasco E.   +10 more
europepmc   +1 more source

High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection. [PDF]

Eur J Med Res, 2022
de Castro GLC, da Silva Graça Amoras E, Araújo MS, da Silva Conde SRS, Bichara CDA, Queiroz MAF, Vallinoto ACR.   +6 more
europepmc   +1 more source

Antinuclear Antibody Reduces the Pregnancy Rate in the First IVF‐ET Treatment Cycle but Not the Cumulative Pregnancy Rate without Specific Medication [PDF]

, 2003
Kumiko Kikuchi, Hiroaki Shibahara, Yuki Hirano, Takahiro Kohno, Chikako Hirashima, Tatsuya Suzuki, Satoru Takamizawa, Mitsuaki Suzuki   +7 more
openalex   +1 more source

ANTINUCLEAR ANTIBODIES IN ENDOMETRIOSIS

SBR 2021 Congresso Brasileiro de Reumatologia, 2021
Laís Zanlorenzi, Nelzi Ferreira de Queiroz Junior, Renato Nishiara, Carlos Gomes Bezerra Sobrinh, Thelma Larocca Skare, Laura Vilas Boas   +5 more
openaire   +1 more source

Post‐COVID‐19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies

The Journal of Pathology, Volume 266, Issue 4-5, Page 369-389, August 2025.
Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk, Guolu Tang, Arno R Bourgonje, Wilfred F A den Dunnen, Jan‐Luuk Hillebrands, Harry van Goor   +5 more
wiley   +1 more source

Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis. [PDF]

J Oral Biol Craniofac Res
Krishnan Pandarathodiyil A, Shree K H, Ramani P, Sivapathasundharam B, Ramadoss R.   +4 more
europepmc   +1 more source

Expanded assessment of xenobiotic associations with antinuclear antibodies in the United States, 1988-2012. [PDF]

Environ Int, 2022
Dinse GE, Co CA, Parks CG, Weinberg CR, Xie G, Chan EKL, Birnbaum LS, Miller FW.   +7 more
europepmc   +1 more source

Evaluation of the New Multiplexed Immunoassay, FIDIS, for Simultaneous Quantitative Determination of Antinuclear Antibodies and Comparison With Conventional Methods [PDF]

, 2003
Anne-Marie Rouquette, Chantal Desgruelles, Pascale Laroche   +2 more
openalex   +1 more source

Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review

Pediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly) syndrome is a rare, life‐threatening inflammatory condition linked to infections, neoplasms, and idiopathic multicentric Castleman disease. Interleukin (IL)‐6 inhibitors are the primary treatment, but refractory cases require alternatives. This
Serena Palmeri, Jacopo Ferro, Valentina Natoli, Caterina Matucci‐Cerinic, Riccardo Papa, Silvia Rosina, Stefania Sorrentino, Stefano Volpi, Valerio Gaetano Vellone, Marco Gattorno, Roberta Caorsi   +10 more
wiley   +1 more source

The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome. [PDF]

Clin Exp Med
Shao H, Wu Y, Tao X, Liu Q, Ran C, Jin L, Tao J.   +6 more
europepmc   +1 more source